Use of anticoagulant or antiplatelet agents is not related to epistaxis in patients undergoing transnasal endoscopy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Use of anticoagulant or antiplatelet agents is not related to epistaxis in patients undergoing transnasal endoscopy ; volume:06 ; number:01 ; year:2018 ; pages:E104-E110
Endoscopy International Open ; 06, Heft 01 (2018), E104-E110
- Beteiligte Personen und Organisationen
-
Kobayashi, Yoshiya
Komazawa, Yoshinori
Yuki, Mika
Ishitobi, Hitomi
Nagaoka, Makoto
Takahashi, Yoshiko
Nakashima, Sayaka
Shizuku, Toshihiro
Kinoshita, Yoshikazu
- DOI
-
10.1055/s-0043-124366
- URN
-
urn:nbn:de:101:1-2019021806073189509770
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kobayashi, Yoshiya
- Komazawa, Yoshinori
- Yuki, Mika
- Ishitobi, Hitomi
- Nagaoka, Makoto
- Takahashi, Yoshiko
- Nakashima, Sayaka
- Shizuku, Toshihiro
- Kinoshita, Yoshikazu
Ähnliche Objekte (12)
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Splenic Rupture following Transnasal Endoscopy
Antiplatelet agents
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Risk factors for severe bleeding complications in glaucoma surgery and the role of antiplatelet or anticoagulant agents
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Splenic Rupture following Transnasal Endoscopy
Antiplatelet agents
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Risk factors for severe bleeding complications in glaucoma surgery and the role of antiplatelet or anticoagulant agents
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Splenic Rupture following Transnasal Endoscopy
Antiplatelet agents
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Risk factors for severe bleeding complications in glaucoma surgery and the role of antiplatelet or anticoagulant agents
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs